Scandion Oncology
Overcoming cancer drug resistance
Navbar
About us
Executive Management
Board of Directors
Clinical Advisory Board
Research & Development
Pipeline
Clinical Development
Science
Cancer drug resistance
Technology Platform
SCO-101
Press releases
Investors & Media
Share information
Financial Reports
Annual reports
Interim reports
Year-end reports
Presentations
Media
Image library
Video library
Analyst Coverage
Prospectuses
Rights Issue 2022
Rights Issue 2020
Rights Issue 2019
Subscription Warrant (SCOL TO 1)
IPO 2018
Corporate governance
Events
Financial calendar
General meetings
Contact
Career
Business development
Skip to content
Regulatory
19 May 2022
Press releases
Choose year
2023
2022
2021
2020
2019
2018
2017
All
Annual report
Interim Report
News
Newsletter
Press release
Year end report
Regulatory posts
19 May 2022
Scandion Oncology – Interim Report Q1 2022
Download
Presentation
Webcast
Workbook
20 May 2021
Q1 2021 Report: Scandion Oncology is evolving
Download
Presentation
Webcast
Workbook
21 May 2020
Interim report 1 January – 31 March 2020
Download
Presentation
Webcast
Workbook
27 May 2019
Interim report 1 January – 31 March 2019
Download
Presentation
Webcast
Workbook